Sickle cell disease Haematological Disorders Sickle-cell anaemia without crisis
Conditions
Interventions
The study will be an observational trial, revolving around the use of a mobile app by participants in order to provide initial consent to participate and share their medical records with the study, ke
Sponsors
Eleven
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Children with sickle cell disease of any phenotype aged 5-15 years of age, with consent from and attendance/guidance by parent or legal guardian 2. Adults with sickle cell disease of any phenotype aged 16 years and over 3. Able and willing to sign written informed consent 4. Interest in participating in the study 5. Known history/diagnosis of sickle cell disease
Exclusion criteria
Exclusion criteria: 1. Incapacity to provide informed written consent 2. Known allergic reaction to any materials in wearable device
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Recruitment rate recorded as the number of eligible participants who consent to participate in the study by 3 months 2. Attrition rate recorded as the number of participants who consent to participate that remain in the study until the end of the follow-up period at 13 months | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, United Kingdom
Contacts
Public ContactKim Summers
Outcome results
None listed